Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.
Hoskin PJ, Hopkins K, Misra V, Holt T, McMenemin R, Dubois D, McKinna F, Foran B, Madhavan K, MacGregor C, Bates A, O'Rourke N, Lester JF, Sevitt T, Roos D, Dixit S, Brown G, Arnott S, Thomas SS, Forsyth S, Beare S, Reczko K, Hackshaw A, Lopes A. Hoskin PJ, et al. Among authors: reczko k. JAMA. 2019 Dec 3;322(21):2084-2094. doi: 10.1001/jama.2019.17913. JAMA. 2019. PMID: 31794625 Free PMC article. Clinical Trial.
Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
Hackshaw A, Baum M, Fornander T, Nordenskjold B, Nicolucci A, Monson K, Forsyth S, Reczko K, Johansson U, Fohlin H, Valentini M, Sainsbury R. Hackshaw A, et al. Among authors: reczko k. J Natl Cancer Inst. 2009 Mar 4;101(5):341-9. doi: 10.1093/jnci/djn498. Epub 2009 Feb 24. J Natl Cancer Inst. 2009. PMID: 19244174 Free PMC article. Clinical Trial.
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer.
Hoskin P, Sundar S, Reczko K, Forsyth S, Mithal N, Sizer B, Bloomfield D, Upadhyay S, Wilson P, Kirkwood A, Stratford M, Jitlal M, Hackshaw A. Hoskin P, et al. Among authors: reczko k. J Natl Cancer Inst. 2015 Aug 4;107(10):djv197. doi: 10.1093/jnci/djv197. Print 2015 Oct. J Natl Cancer Inst. 2015. PMID: 26242893 Clinical Trial.
Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trial.
Hoskin PJ, Hopkins K, Misra V, Holt T, McMenemin R, McKinna F, Madhavan K, Bates A, O'Rourke N, Lester JF, Sevitt T, Roos D, Brown G, Thomas SS, Forsyth S, Reczko K, Hackshaw A, O'Hara C, Lopes A. Hoskin PJ, et al. Among authors: reczko k. Radiother Oncol. 2022 Aug;173:77-83. doi: 10.1016/j.radonc.2022.05.017. Epub 2022 May 23. Radiother Oncol. 2022. PMID: 35618101 Clinical Trial.
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
Taylor SA, Mallett S, Beare S, Bhatnagar G, Blunt D, Boavida P, Bridgewater J, Clarke CS, Duggan M, Ellis S, Glynne-Jones R, Goh V, Groves AM, Hameeduddin A, Janes SM, Johnston EW, Koh DM, Miles A, Morris S, Morton A, Navani N, O'Donohue J, Oliver A, Padhani AR, Pardoe H, Patel U, Punwani S, Quinn L, Rafiee H, Reczko K, Rockall AG, Shahabuddin K, Sidhu HS, Teague J, Thaha MA, Train M, van Ree K, Wijeyekoon S, Halligan S; Streamline investigators. Taylor SA, et al. Among authors: reczko k. Lancet Gastroenterol Hepatol. 2019 Jul;4(7):529-537. doi: 10.1016/S2468-1253(19)30056-1. Epub 2019 May 9. Lancet Gastroenterol Hepatol. 2019. PMID: 31080095 Free PMC article. Clinical Trial.
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
Taylor SA, Mallett S, Ball S, Beare S, Bhatnagar G, Bhowmik A, Boavida P, Bridgewater J, Clarke CS, Duggan M, Ellis S, Glynne-Jones R, Goh V, Groves AM, Hameeduddin A, Janes SM, Johnston EW, Koh DM, Lock S, Miles A, Morris S, Morton A, Navani N, Oliver A, O'Shaughnessy T, Padhani AR, Prezzi D, Punwani S, Quinn L, Rafiee H, Reczko K, Rockall AG, Russell P, Sidhu HS, Strickland N, Tarver K, Teague J, Halligan S; Streamline investigators. Taylor SA, et al. Among authors: reczko k. Lancet Respir Med. 2019 Jun;7(6):523-532. doi: 10.1016/S2213-2600(19)30090-6. Epub 2019 May 9. Lancet Respir Med. 2019. PMID: 31080129 Free PMC article. Clinical Trial.
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
Miles A, Taylor SA, Evans REC, Halligan S, Beare S, Bridgewater J, Goh V, Janes S, Navani N, Oliver A, Morton A, Rockall A, Clarke CS, Morris S; STREAMLINE investigators. Miles A, et al. Eur Radiol. 2019 Jul;29(7):3889-3900. doi: 10.1007/s00330-019-06153-4. Epub 2019 Apr 1. Eur Radiol. 2019. PMID: 30937589 Free PMC article.
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
Miles A, Evans RE, Halligan S, Beare S, Bridgewater J, Goh V, Janes SM, Navani N, Oliver A, Morton A, Morris S, Rockall A, Taylor SA; STREAMLINE investigators. Miles A, et al. J Med Imaging Radiat Oncol. 2020 Aug;64(4):537-545. doi: 10.1111/1754-9485.13038. Epub 2020 May 14. J Med Imaging Radiat Oncol. 2020. PMID: 32410378 Free PMC article.
18 results